Novanta (NASDAQ:NOVT – Get Free Report) is projected to post its Q3 2025 results before the market opens on Tuesday, November 4th. Analysts expect Novanta to post earnings of $0.81 per share and revenue of $245.9460 million for the quarter. Novanta has set its FY 2025 guidance at 3.220-3.360 EPS. Q3 2025 guidance at 0.780-0.850 EPS.Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 8:30 AM ET.
Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The technology company reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.02. The business had revenue of $241.05 million during the quarter, compared to the consensus estimate of $237.97 million. Novanta had a return on equity of 14.70% and a net margin of 6.41%.Novanta’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 earnings per share. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Novanta Stock Performance
NASDAQ NOVT opened at $127.01 on Monday. The company has a market capitalization of $4.57 billion, a price-to-earnings ratio of 74.71 and a beta of 1.49. Novanta has a twelve month low of $98.76 and a twelve month high of $184.11. The stock has a fifty day simple moving average of $112.37 and a 200 day simple moving average of $119.56. The company has a quick ratio of 1.62, a current ratio of 2.54 and a debt-to-equity ratio of 0.57.
Analysts Set New Price Targets
A number of research firms recently weighed in on NOVT. Zacks Research upgraded Novanta from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Weiss Ratings downgraded Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a report on Saturday, October 25th. Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a report on Monday, August 11th. Finally, Robert W. Baird decreased their price objective on Novanta from $139.00 to $133.00 and set a “neutral” rating for the company in a report on Monday, August 11th. Two analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Novanta has a consensus rating of “Reduce” and an average target price of $133.00.
Read Our Latest Analysis on Novanta
Institutional Trading of Novanta
A number of large investors have recently bought and sold shares of NOVT. AQR Capital Management LLC grew its holdings in Novanta by 78.9% during the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock worth $537,000 after acquiring an additional 1,866 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Novanta by 1.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock worth $53,582,000 after purchasing an additional 6,533 shares in the last quarter. Jane Street Group LLC boosted its position in shares of Novanta by 1,762.5% during the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock worth $7,881,000 after purchasing an additional 58,322 shares in the last quarter. First Trust Advisors LP bought a new position in shares of Novanta during the 2nd quarter worth about $528,000. Finally, Amundi boosted its position in shares of Novanta by 2.0% during the 2nd quarter. Amundi now owns 18,042 shares of the technology company’s stock worth $2,397,000 after purchasing an additional 347 shares in the last quarter. 98.35% of the stock is currently owned by institutional investors and hedge funds.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- How to Calculate Options Profits
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- Growth Stocks: What They Are, What They Are Not
- Caterpillar Stock Could Top $650 by Year’s End
- Insider Trading – What You Need to Know
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
